期刊文献+

进展期胃癌术后早期腹腔灌注化疗对患者生存期和复发率影响的Meta分析 被引量:6

Impact of Early Postoperative Intraperitoneal Chemotherapy on Clinical Survival and Recurrence Rates in Treatment of Advanced Gastric Cancer:A Meta Analysis
下载PDF
导出
摘要 目的探讨术后早期腹腔灌注化疗在进展期胃癌治疗中的作用。方法计算机检索Cochrane Library、PubMed、EMBASE、中国生物医学文献数据库、中国期刊全文数据库、中文科技期刊全文数据库,检索时间从各数据库建库至2010年9月;同时辅助其他检索,纳入胃癌术后早期腹腔灌注化疗治疗进展期胃癌的随机对照试验(RCT)。由两名评价者独立评价纳入研究的质量并提取资料,并用RevMan 5.0软件进行统计分析。结果共纳入9篇RCT,共1 171例患者。Meta分析结果显示:与单纯全身静脉化疗比较,术后早期腹腔灌注化疗可以提高进展期胃癌患者的1、2、3、5年生存率,也可以降低患者2、3年复发率及腹腔内复发率,同时亦可以降低患者恶心呕吐的发生率,减轻患者的骨髓抑制和肝肾功能损害。结论进展期胃癌术后早期腹腔灌注化疗可以提高患者生存率,减少术后复发率,减轻化疗的毒副作用。 Objective To evaluate the effects of early postoperative intraperitoneal chemotherapy in the treatment of advanced gastric cancer.Methods We searched Cochrane Library,PubMed,EMBASE,Chinese Biomedical Literature Database,China Academic Journal,Chinese Science and Technology Journal Full-text database for literatures published between the establishment of these databases and September 2010.We also traced related references and experts in this field,as well as communicated with other authors to obtain certain information that had not been found.Randomized controlled trials of early postoperative intraperitoneal chemotherapy in treatment of gastric cancer were included.We evaluated the quality of these studies and analyzed the data by Cochrane Collaboration's RevMan 5.0 software.Results Nine RCTs(1171 patients altogether) were included.Meta-analysis results showed that compared with intravenous chemotherapy alone,early postoperative intraperitoneal chemotherapy improved 1,2,3 and 5-year survival rates and reduced 2 and 3-year relapse rates and intra-abdominal recurrence.Meanwhile,early postoperative intraperitoneal chemotherapy reduced the incidence of nausea and vomiting and displayed a protective effect on liver function and renal function.Conclusion Compared with intravenous chemotherapy,early postoperative intraperitoneal chemotherapy improves survival rate and reduces both recurrence rate and toxic side effects in advanced gastric cancer patients.
出处 《中国全科医学》 CAS CSCD 北大核心 2011年第30期3487-3490,共4页 Chinese General Practice
基金 兰州大学2010年本科生创新创业计划项目
关键词 进展期胃癌 腹腔化疗 META分析 Advanced gastric cancer Intraperitoneal chemotherapy Meta-analysis
  • 相关文献

参考文献11

二级参考文献31

共引文献11

同被引文献68

  • 1崔书中.腹腔热灌注化疗在胃癌治疗中的应用新进展[J].消化肿瘤杂志(电子版),2012,4(4):211-216. 被引量:8
  • 2万崇华,陈明清,张灿珍,汤学良,孟琼,张晓磬.癌症患者生命质量测定量表EORTC QLQ-C30中文版评介[J].实用肿瘤杂志,2005,20(4):353-355. 被引量:1317
  • 3邹建军,郑莹,钱建新,顾小强,王杰军.上海市部分社区癌症患者生活质量影响因素的研究[J].中华流行病学杂志,2005,26(10):761-766. 被引量:21
  • 4刘先领,马芳,胡春宏,黄明,龚海云.腔内灌注化疗联合全身热疗治疗恶性胸腹腔积液临床研究[J].中国现代医学杂志,2006,16(6):939-940. 被引量:19
  • 5李景武,梁寒,王晓娜.814例胃癌患者的预后因素分析[J].中国肿瘤临床,2006,33(7):399-402. 被引量:37
  • 6Muggia FM,Braly PS,Brady MF,et al.Phase Ⅲ randomized study of cisplatin versus pacli-taxel versus cisplatin and paclitaxel in patients with suboptimal stage Ⅲ or Ⅳ ovarian cancer:A Gynecologic Oncology Group study[J].J Clin Oncol,2000,18:106-115.
  • 7Ozols RF,Bundy BN,Greer BE,et al.Gynecologic Oncology Group.Phase Ⅲ trial of carbo-platin and paclitaxel compared with cisplatin andpaclitaxel in patients with optimally resected stage Ⅲ ovarian cancer:A Gynecologic Oncology Group study[J].J Clin Oncol,2003,21:3194 -3200.
  • 8Alberts DS,Green S,Hannigan EV,et al.Improved therapeutic index of carboplatin plus cyclo-phosphamide versus cisplatin plus cyclophosphamide:final report by the Southwest Oncology Group of a phase Ⅲ randomized trial in stages Ⅲ and Ⅳ ovarian cancer[J].J Clin Oncol,1992,10:706-717.
  • 9Gadducci A,Conte PF.Intraperitoneal chemotherapy in the management of patients with ad-vanced epithelial ovarian cancer:a critical review of the literature[J].Int J Gynecol Cancer,2008,18:943-953.
  • 10Elit L,Oliver TK,Covens A,et al.Intraperitoneal chemotherapy in the first-line treatment of women with stage Ⅲ epithelial ovarian cancer:a systematic review with metaanalyses[J].Cancer,2007,109:692-702.

引证文献6

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部